Gene therapy for glioblestome multiforme: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir

被引:0
|
作者
G. Stockhammer
J. Brotchi
R. Leblanc
M. Bernstein
G. Schackert
F. Weber
C. Ostertag
N. H. Mulder
H. Mellstedt
R. Seiler
Y. Yonekawa
K. Twerdy
H. Kostron
O. De Witte
M. Lambermont
T. Velu
P. Laneuville
J.-G. Villemure
J. T. Rutka
P. Warnke
M. Laseur
J. J. A. Mooij
J. Boëthius
L. Mariani
M. Meyer
C. Brändli
K. Frei
D. Könu
A. Gianella-Borradori
机构
[1] Sandoz Pharma,
[2] Ltd.,undefined
[3] CH-4002 Basel,undefined
[4] Switzerland,undefined
[5] University of Innsbruck,undefined
[6] Innsbruck,undefined
[7] Austria,undefined
[8] Hôpital Erasme,undefined
[9] Brussels,undefined
[10] Belgium,undefined
[11] Montreal Neurological Institute,undefined
[12] Montreal,undefined
[13] Quebec,undefined
[14] Canada,undefined
[15] Royal Victoria Hospital,undefined
[16] Montreal,undefined
[17] Quebec,undefined
[18] Canada,undefined
[19] Toronto Hospital,undefined
[20] Toronto,undefined
[21] Ontario,undefined
[22] Canada,undefined
[23] Hospital for Sick Children,undefined
[24] Toronto,undefined
[25] Ontario,undefined
[26] Canada,undefined
[27] Universitätsklinikum Karl Gustav Carus,undefined
[28] Dresden,undefined
[29] Germany,undefined
[30] Universitätsklinikum,undefined
[31] Düsseldorf,undefined
[32] Germany,undefined
[33] Neurozentrum Freiburg,undefined
[34] Freiburg,undefined
[35] Germany,undefined
[36] University Hospital Groningen,undefined
[37] Groningen,undefined
[38] The Netherlands,undefined
[39] Karolinska Hospital,undefined
[40] Stockholm,undefined
[41] Sweden,undefined
[42] Inselspital,undefined
[43] Bern,undefined
[44] Switzerland,undefined
[45] Universitätsspital,undefined
[46] Zürich,undefined
[47] Switzerland,undefined
来源
关键词
Gene Therapy; Thymidine; Herpes Simplex; Ganciclovir; Thymidine Kinase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:300 / 304
页数:4
相关论文
共 50 条
  • [1] Gene therapy for glioblestome multiforme: In vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
    Stockhammer, G
    Brotchi, J
    Leblanc, R
    Bernstein, M
    Schackert, G
    Weber, F
    Ostertag, C
    Mulder, NH
    Mellstedt, H
    Seiler, R
    Yonekawa, Y
    Twerdy, K
    Kostron, H
    DeWitte, O
    Lambermont, M
    Velu, T
    Laneuville, P
    Villemure, JG
    Rutka, JT
    Warnke, P
    Laseur, M
    Mooij, JJA
    Boethius, J
    Mariani, L
    Meyer, M
    Brandli, C
    Frei, K
    Konu, D
    GianellaBorradori, A
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (04): : 300 - 304
  • [2] A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
    Shand, N
    Weber, F
    Mariani, L
    Bernstein, M
    Gianella-Borradori, A
    Long, Z
    Sorensen, AG
    Barbier, N
    HUMAN GENE THERAPY, 1999, 10 (14) : 2325 - 2335
  • [3] Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme
    Voges, J
    Weber, F
    Reszka, R
    Sturm, V
    Jacobs, A
    Heiss, WD
    Wiestler, O
    Kapp, JF
    HUMAN GENE THERAPY, 2002, 13 (05) : 675 - 685
  • [4] Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
    Eastham, JA
    Chen, SH
    Sehgal, I
    Yang, G
    Timme, TL
    Hall, SJ
    Woo, SLC
    Thompson, TC
    HUMAN GENE THERAPY, 1996, 7 (04) : 515 - 523
  • [5] GENE-THERAPY FOR THE TREATMENT OF MALIGNANT BRAIN-TUMORS WITH IN-VIVO TUMOR TRANSDUCTION WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE GANCICLOVIR SYSTEM
    CULVER, KW
    VANGILDER, J
    LINK, CJ
    CARLSTROM, T
    BUROKER, T
    YUH, W
    KOCH, K
    SCHABOLD, K
    DOORNBAS, S
    WETJEN, B
    BLAESE, RM
    HUMAN GENE THERAPY, 1994, 5 (03) : 343 - 379
  • [6] GENE-THERAPY FOR THE TREATMENT OF RECURRENT PEDIATRIC MALIGNANT ASTROCYTOMAS WITH IN-VIVO TUMOR TRANSDUCTION WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE GANCICLOVIR SYSTEM
    RAFFEL, C
    CULVER, K
    KOHN, D
    NELSON, M
    SIEGEL, S
    GILLIS, F
    LINK, CJ
    VILLABLANCA, JG
    ANDERSON, WF
    HUMAN GENE THERAPY, 1994, 5 (07) : 863 - 890
  • [7] Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy
    PD Boucher
    LJ Ostruszka
    PJM Murphy
    DS Shewach
    Gene Therapy, 2002, 9 : 1023 - 1030
  • [8] Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy
    Boucher, PD
    Ostruszka, LJ
    Murphy, PJM
    Shewach, DS
    GENE THERAPY, 2002, 9 (15) : 1023 - 1030
  • [9] Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy
    Izquierdo, M
    Martin, V
    deFelipe, P
    Izquierdo, JM
    PerezHigueras, A
    Cortes, ML
    Paz, JF
    Isla, A
    Blazquez, MG
    GENE THERAPY, 1996, 3 (06) : 491 - 495
  • [10] Gene therapy for retinoblastoma: Comparison of gene replacement with the retinoblastoma gene to suicide gene therapy with herpes simplex thymidine kinase and ganciclovir
    Hurwitz, RL
    Rivera, AL
    Holcombe, VN
    Chevez-Barrios, P
    Hurwitz, MY
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S761 - S761